向日葵籽仁 对肾病患者 避免
Avoid or eat rarely if you have CKD · 依据 USDA 与 KDOQI 指南验证。
向日葵籽仁 — kidney-friendly food
CKD 每日限值占比
Phosphorus
73%
Sodium
0%
Potassium
33%
基于 CKD 3–4 期每日限值
零食 Avoid

向日葵籽仁

每 100gram 份的营养成分与 CKD 安全等级

分量 100.0 gram
5gram ← 拖动调整 → 500gram
热量
0 kcal
蛋白质
18.9 g
碳水化合物
24.5 g
脂肪
48.4 g
732 mg
占每日 1,000毫克 CKD 限值的 73%
0 mg
占每日 2,300毫克 CKD 限值的 0%
656 mg
占每日 2,000毫克 CKD 限值的 33%
结论:对 CKD 而言避免

向日葵籽仁 的含量显著超过 CKD 友好阈值。请避免常规食用。若必须食用(例如特殊场合),请将分量控制到极小,并相应调整当日其他饮食。

请务必咨询您的肾科医生或注册营养师 — 不同 CKD 阶段与化验值因人而异。

肾友替代品

零食 中寻找更安全的选择?可以试试这些:

常见问题

Is 向日葵籽仁 safe for people with kidney disease?
向日葵籽仁 is rated Avoid for CKD patients. Avoid or eat rarely if you have CKD. With 732.0mg phosphorus, 0.0mg sodium, and 656.8mg potassium per 100.0g serving, it is best avoided or eaten only on special occasions. Always confirm with your nephrologist or renal dietitian.
How much phosphorus is in 向日葵籽仁?
A 100.0g serving of 向日葵籽仁 contains 732mg of phosphorus, which is approximately 73% of the recommended 1,000mg daily limit for CKD Stage 3-4 patients.
How much sodium is in 向日葵籽仁?
Per 100.0g serving, 向日葵籽仁 provides 0mg of sodium — about 0% of the 2,300mg daily sodium limit recommended for kidney patients.
How much potassium is in 向日葵籽仁?
向日葵籽仁 contains 656mg of potassium per 100.0g serving, equivalent to about 33% of the daily 2,000mg potassium limit for CKD Stage 3-4 patients.
Can dialysis patients eat 向日葵籽仁?
Dialysis patients have stricter mineral limits. Given 向日葵籽仁 is rated Avoid (Avoid or eat rarely if you have CKD), dialysis patients should consult their dietitian before consuming this food. Your dialysis team can give you personalised portion advice.

在哪里购买 向日葵籽仁

Shop from trusted retailers — we may earn a small commission at no extra cost.

a
Shop 向日葵籽仁 on Amazon
Prime delivery Subscribe & Save Free returns
Shop now
Affiliate Disclosure: As an Amazon Associate, KidneyFoods earns from qualifying purchases. This helps keep the site free — at no extra cost to you.

更多零食

Last updated: March 15, 2026 · Data source: USDA FoodData Central & KDOQI guidelines